Monoclonal Antibodies Targeting CGRP: A Novel Treatment in Vestibular Migraine

Background. Monoclonal antibodies (mAbs) directed against the calcitonin gene-related peptide (CGRP) or its receptor represented the first targeted and specialized approach to migraine prophylaxis. Nevertheless, they have been rarely considered in the treatment of vestibular migraine (VM). Our aim w...

Descripción completa

Detalles Bibliográficos
Autores principales: Lovato, Andrea, Disco, Caterina, Frosolini, Andrea, Monzani, Daniele, Perini, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534399/
https://www.ncbi.nlm.nih.gov/pubmed/37763679
http://dx.doi.org/10.3390/medicina59091560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534399/
https://www.ncbi.nlm.nih.gov/pubmed/37763679
http://dx.doi.org/10.3390/medicina59091560

Ejemplares similares